Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van der Ende

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Scientific Reports|February 4, 2024
Prevalence and associated factors of worry for cancer in patients with a Barrett's esophagusM C M van der Ende-van Loon, R A B Oude Nijhuis, W L Curvers, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 8, 2021
How are we measuring health-related quality of life in patients with a Barrett Esophagus? A systematic review on patient-reported outcome measurementsMirjam C M van der Ende-van Loon, A Stoker, P T Nieuwkerk, et al.
JIMD Reports|November 4, 2015
Normoglycemic Ketonemia as Biochemical Presentation in Ketotic Glycogen Storage DiseaseIrene J Hoogeveen, Rixt M van der Ende, Francjan J van Spronsen, et al.
Journal of Patient-Reported Outcomes|October 30, 2023
Translation, validation and psychometric properties of the Dutch version of the Inflammatory Bowel Disease-Fatigue (IBD-F) self-assessment scaleAnnemay M H Stoker, Angélique Gruters, Mirjam C M van der Ende-van Loon, et al.
Molecular Genetics and Metabolism|July 8, 2019
Changes in pediatric plasma acylcarnitines upon fasting for refined interpretation of metabolic stressWillemijn J van Rijt, Rixt M van der Ende, Catharina M L Volker-Touw, et al.
Clinical and Experimental Medicine|January 12, 2023
Relapse rates after withdrawal versus maintaining biologic therapy in IBD patients with prolonged remissionAnnemay M H Stoker, Leslie Logghe, Mirjam C M van der Ende-van Loon, et al.
Antiviral Therapy|April 1, 1996
Tolerability and activity of a new recombinant interferon-alpha B/D hybrid in patients with HIV-1 infectionP H Frissen, K Brinkman, C H Ten Napel, et al.
The New England Journal of Medicine|December 24, 1992
A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment GroupM M Schneider, A I Hoepelman, J K Eeftinck Schattenkerk, et al.
Scientific Reports|October 6, 2022
Artificial intelligence in (gastrointestinal) healthcare: patients' and physicians' perspectivesQuirine E W van der Zander, Mirjam C M van der Ende-van Loon, Janneke M M Janssen, et al.
Neurology|January 4, 2023
Disentangling the Association Between Neurologic Deficits, Patient-Reported Impairments, and Quality of Life After Ischemic StrokeNadinda A M van der Ende, Sanne J den Hartog, Joseph P Broderick, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Scientific Reports|February 4, 2024
Prevalence and associated factors of worry for cancer in patients with a Barrett's esophagusM C M van der Ende-van Loon, R A B Oude Nijhuis, W L Curvers, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 8, 2021
How are we measuring health-related quality of life in patients with a Barrett Esophagus? A systematic review on patient-reported outcome measurementsMirjam C M van der Ende-van Loon, A Stoker, P T Nieuwkerk, et al.
JIMD Reports|November 4, 2015
Normoglycemic Ketonemia as Biochemical Presentation in Ketotic Glycogen Storage DiseaseIrene J Hoogeveen, Rixt M van der Ende, Francjan J van Spronsen, et al.
Journal of Patient-Reported Outcomes|October 30, 2023
Translation, validation and psychometric properties of the Dutch version of the Inflammatory Bowel Disease-Fatigue (IBD-F) self-assessment scaleAnnemay M H Stoker, Angélique Gruters, Mirjam C M van der Ende-van Loon, et al.
Molecular Genetics and Metabolism|July 8, 2019
Changes in pediatric plasma acylcarnitines upon fasting for refined interpretation of metabolic stressWillemijn J van Rijt, Rixt M van der Ende, Catharina M L Volker-Touw, et al.
Clinical and Experimental Medicine|January 12, 2023
Relapse rates after withdrawal versus maintaining biologic therapy in IBD patients with prolonged remissionAnnemay M H Stoker, Leslie Logghe, Mirjam C M van der Ende-van Loon, et al.
Antiviral Therapy|April 1, 1996
Tolerability and activity of a new recombinant interferon-alpha B/D hybrid in patients with HIV-1 infectionP H Frissen, K Brinkman, C H Ten Napel, et al.
The New England Journal of Medicine|December 24, 1992
A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment GroupM M Schneider, A I Hoepelman, J K Eeftinck Schattenkerk, et al.
Scientific Reports|October 6, 2022
Artificial intelligence in (gastrointestinal) healthcare: patients' and physicians' perspectivesQuirine E W van der Zander, Mirjam C M van der Ende-van Loon, Janneke M M Janssen, et al.
Neurology|January 4, 2023
Disentangling the Association Between Neurologic Deficits, Patient-Reported Impairments, and Quality of Life After Ischemic StrokeNadinda A M van der Ende, Sanne J den Hartog, Joseph P Broderick, et al.
Pageof 4